Continually Updated Clinical Reference
 
 
  All Sources     eMedicine     Medscape     Drug Reference     MEDLINE
 
You are in: eMedicine Specialties > Emergency Medicine > Endocrine And Metabolic

Hyperosmolar Hyperglycemic Nonketotic Coma

Last Updated: January 13, 2005
Email to a Colleague
Synonyms and related keywords: HHNC, hyperosmolar coma, diabetic nonketotic coma, hyperosmolar nonketotic state, diabetic hyperosmolarity, diabetes, hyperglycemia, diabetic ketoacidosis, DKA, adult-onset diabetes, dehydration, sepsis, pneumonia, urinary tract infection, UTI, diuretics, beta-blockers, histamine 2 blockers, H2 blockers, stroke, intracranial hemorrhage, acute myocardial infarction, acute MI, acute heart attack, dialysis, gastrointestinal hemorrhage, hyponatremia

  AUTHOR INFORMATION Section 1 of 10    Click here to go to the next section in this topic
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

Author: Mark Sagarin, MD, Assistant Professor, Department of Emergency Medicine, University of New Mexico Health Sciences Center

Coauthor(s): Andrew McAfee, MD, Consulting Staff, Department of Emergency Medicine, Brigham and Women's Hospital

Mark Sagarin, MD, is a member of the following medical societies: American Academy of Emergency Medicine

Editor(s): Joseph J Sachter, MD, FACEP, Consulting Staff, Department of Emergency Medicine, Muhlenberg Regional Medical Center; Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine; Howard A Bessen, MD, Professor of Medicine, UCLA School of Medicine; Program Director, Department of Emergency Medicine, Harbor-UCLA Medical Center; John Halamka, MD, Chief Information Officer, CareGroup Healthcare System, Assistant Professor of Medicine, Department of Emergency Medicine, Beth Israel Deaconess Medical Center; Assistant Professor of Medicine, Harvard Medical School; and Craig Feied, MD, FACEP, FAAEM, FACPh, Professor of Emergency Medicine, Georgetown University, Director, National Institute for Medical Informatics, Director, Federal Project ER One, Director, National Center for Emergency Medicine Informatics

Disclosure


  INTRODUCTION Section 2 of 10   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

Background: Hyperosmolar hyperglycemic nonketotic coma (HHNC) is a metabolic derangement that occurs principally in patients with adult-onset diabetes. The condition is characterized by hyperglycemia, hyperosmolarity, and an absence of significant ketosis.

Despite the name, coma is present in fewer than 10% of cases. Most patients present with severe dehydration and focal or global neurologic deficits. In many cases, the clinical features of HHNC and diabetic ketoacidosis (DKA) overlap and are observed simultaneously.

Pathophysiology: HHNC most commonly develops in patients with diabetes who have some concomitant illness that leads to a reduced fluid intake. Infection is the most common cause, but many other conditions can cause altered mentation and/or dehydration. Frequently, this concomitant illness is not identifiable.

Hyperglycemia and hyperosmolarity lead to osmotic diuresis and an osmotic shift of fluid to the intravascular space, resulting in further intracellular dehydration.

Unlike patients with DKA, patients with HHNC do not develop ketoacidosis, but the reason for this is not known. Contributing factors include the limitation on ketogenesis by hyperosmolarity, the lower levels of free fatty acids available for ketogenesis, the availability of insulin in amounts sufficient to inhibit ketogenesis but not sufficient to prevent hyperglycemia, and the hepatic resistance to glucagon in these patients.

Frequency:

  • In the US: The incidence is 17.5 cases per 100,000 people. This incidence is slightly higher than the incidence of DKA.

Mortality/Morbidity: The mortality rate is high (10-20%).

Sex: The prevalence is slightly higher in females than in males.

Age:

  • HHNC has a mean age of onset early in the seventh decade of life.
  • In contrast, the mean age for DKA is early in the fourth decade of life.
  • Residents of nursing facilities who are elderly and demented are at the highest risk, but the syndrome has been reported in patients as young as 18 months.


  CLINICAL Section 3 of 10   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

History:

  • Most patients with HHNC have a known history of diabetes, which is usually adult onset.
  • One third of patients with HHNC do not have a prior diagnosis of diabetes.
  • Often, a preceding illness results in several days of increasing dehydration.
  • Oral hydration usually is impaired by concurrent acute illness or chronic comorbidity (eg, dementia, immobility, vomiting).
  • Severe dehydration initiates a cascade of metabolic derangements that result in progressive dehydration, hyperosmolarity, hyperglycemia, and consequent neurologic derangements.
  • A wide variety of focal and global neurologic changes may be present, including the following:
    • Drowsiness and lethargy
    • Delirium
    • Coma
    • Focal or generalized seizures
    • Visual changes or disturbances
    • Hemiparesis
    • Sensory deficits

Physical: General appearance and hygiene may provide clues to the state of hydration, presence of chronic illness, and reduced level of mentation.

  • Vital signs
    • Tachycardia is an early indicator of dehydration; hypotension is a later sign suggestive of profound dehydration.
    • Orthostatic vital signs are neither sensitive nor specific.
    • Tachypnea may result from respiratory compensation for metabolic acidosis.
    • Assess core temperature rectally. Abnormally high or low temperatures suggest sepsis.
    • Hypoxemia can be a concurrent problem affecting mentation. Administer supplemental oxygen if the patient has any degree of desaturation.
  • Perform a thorough skin examination including a search for sources of infection, such as cellulitis or abscess.
    • Skin turgor is another clue to hydration status.
    • Warm, moist skin suggests early sepsis.
    • Cool, dry skin suggests late sepsis.
  • Examination of the head, eyes, ears, nose, and throat (HEENT) may reveal altered hydration status (eg, sunken eyes, dry mouth) or potential foci of infection (eg, middle ear, sinuses, oropharynx). Cranial neuropathies may be appreciated.
  • Visual field losses and nystagmus sometimes are observed in HHNC.
  • The neck exam may reveal enlarged lymph nodes or meningismus. Palpation of the thyroid may reveal evidence consistent with thyrotoxicosis as a cause for tachycardia, fever, and dehydration.
  • The pulmonary and cardiac examinations may reveal signs of pneumonia or of cardiac diseases. Congestive heart failure (CHF), acute respiratory distress syndrome (ARDS), or atypical pneumonia can be underlying triggers of HHNC.
  • Check for costovertebral angle tenderness as a sign of pyelonephritis.
  • Look for Kernig and Brudzinski signs, which may suggest meningitis.
  • A careful abdominal examination can help to rule out an intraperitoneal infection.
  • Rectal examination can screen for prostatitis, perirectal abscess, and GI hemorrhage.
  • Pelvic examination is indicated in women with lower abdominal pain or purulent discharge.
  • The extremities may give evidence of peripheral volume sequestration or of dehydration.

  • During neurologic examination, evaluate overall mental status, cranial nerves, strength, sensation, reflexes, cerebellar function, stance, and gait. Focal findings may prompt further studies such as CT scan and/or lumbar puncture (LP).

Causes:

  • A preceding or intercurrent illness is common, but the underlying cause may be difficult to ascertain. Pneumonia and urinary tract infections (UTIs) are the most common underlying causes of HHNC.
  • A wide variety of other major illnesses may trigger HHNC by limiting patient mobility and free access to water.
    • Stroke
    • Intracranial hemorrhage
    • Acute myocardial infarction (MI)
    • Gastrointestinal hemorrhage
  • Stress response to any acute illness tends to increase hormones that favor elevated glucose levels. Cortisol, catecholamines, glucagon, and many other hormones have effects that tend to counter those of insulin.
  • Drugs that raise serum glucose, inhibit insulin, or cause dehydration may cause HHNC.
    • Diuretics
    • Beta-blockers
    • Histamine 2 (H2) blockers
    • Dialysis, total parenteral nutrition, and fluids that contain dextrose
  • Elder abuse and neglect also may contribute to underhydration.
  • Noncompliance with oral hypoglycemics or insulin therapy can result in HHNC.
  DIFFERENTIALS Section 4 of 10   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography


Other Problems to be Considered:

Delirium
Dementia
Overdose


Type 2 Diabetes Mellitus Resource Center
Type 2 Diabetes Mellitus Resource Center

View all Type 2 Diabetes Mellitus Articles

Type 2 Diabetes Mellitus Multimedia Library


Quick Find
Author Information
Introduction
Clinical
Differentials
Workup
Treatment
Medication
Follow-up
Miscellaneous
Bibliography

Click for related images.

Related Articles


Patient Education
Click here for patient education.



  WORKUP Section 5 of 10   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

Lab Studies:

  • Serum electrolytes (sodium, potassium, chloride, bicarbonate) and calcium, magnesium, and phosphate
    • Hyponatremia or hypernatremia may be present.

    • In the setting of hyperglycemia, hyponatremia is common due to the osmotic effect of glucose drawing water into the vascular space. Measured serum sodium can be corrected upward 1.6 mEq/L for every 100 mg/dL increase in serum glucose to give an estimate of what the serum sodium level would be in the absence of hyperglycemia and its associated osmotic effect.
  • Total body potassium is likely low regardless of its serum value; a low measured serum potassium suggests profound total body losses.
    • An anion gap metabolic acidosis may be present because of dehydration (lactic acidosis) but usually is less profound than that observed in DKA.

    • Some patients who have primarily a hyperosmolar, hyperglycemic nonketotic state have a component of DKA; therefore, ketoacidosis contributes to the anion gap acidosis.
  • Renal function (BUN and creatinine levels)
    • BUN and creatinine levels are likely to be elevated initially due to dehydration.

    • When possible, they should be compared to previous values, as many patients with diabetes have renal insufficiency at baseline.
  • Serum glucose usually is elevated dramatically, often to greater than 800 mg/dL.
  • Serum osmolarity usually is greater than 320 mOsm/dL.
    • Osmolarity can be measured directly. Predicted osmolarity is calculated using the following formula: Osm = (2 X Na) + (BUN/2.8) + (glucose/18)

    • If the calculated value is significantly lower than the measured value, consider toxic alcohol ingestion as a source of unmeasured osmoles that can trigger HHNC.
  • Serum ketones can be normal in pure HHNC, but mild-to-moderate ketosis can be present when the disease has features both of HHNC and of DKA ("overlap cases").
  • Creatine phosphokinase (CPK) with isoenzymes should be measured routinely because both MI and rhabdomyolysis can trigger HHNC, and both can be secondary complications of HHNC.

  • Acute MI frequently is associated with HHNC.
  • Coagulation studies (prothrombin time [PT] and activated partial thromboplastin time [aPTT]) are useful as part of a screen for disseminated intravascular coagulation (DIC).

  • Blood cultures should be obtained to search for bacteremia.
  • Arterial blood gases
    • ABG is the most accurate indicator of serum pH.
    • A venous blood gas (VBG) may be substituted in patients without any respiratory symptoms who have normal results from a heart/lung exam and normal oxygen saturation on room air. Venous blood gases provide comparable information (assuming that oxygenation and ventilation are adequate) and are easier to draw.
    • In most cases of HHNC, the pH is greater than 7.25.
  • Urinalysis reveals elevated specific gravity (evidence of dehydration), glucosuria, ketonuria, and evidence of UTI.

  • Urine cultures are useful because UTIs may be underdetected by urinalysis alone, particularly in patients with diabetes.
  • Cerebrospinal fluid (CSF) cell count, glucose, protein, and culture are indicated in patients with an acute alteration of consciousness and clinical features suggestive of possible CNS infection. Patients who are immunocompromised may require additional studies of the CSF such as polymerase chain reaction (PCR) for herpes simplex virus (HSV) and cryptococcal antigen.
  • Send for cultures of stool, cervical mucus, and other substances when clinical evidence suggests a potential area of infection.
  • Although not useful in the acute phase of therapy, hemoglobin A1C (glycosylated hemoglobin) may be ordered as an indicator of the patient's glucose control over the previous several weeks.

Imaging Studies:

  • A chest radiograph is useful to screen for pneumonia. Abdominal radiographs are indicated if the patient has abdominal pain or is vomiting.
  • CT scan of the head
    • Indicated in many patients with focal or global neurologic changes
    • May be useful for patients who show no clinical improvement after several hours of treatment, even in the absence of clinical signs of intracranial pathology
    • Indications for head CT scans controversial

Procedures:

  • Venous access
    • Large-bore intravenous (IV) or central venous access is used, especially in cases in which hemorrhage is a precipitant and blood products are likely to be required or when inotropic agents may be necessary.
    • Swan-Ganz catheterization may be helpful in monitoring intravascular volumes.
  • Urethral catheterization is useful to obtain a clean urine specimen. This is especially important if the urine dipstick shows signs of infection.
  • An indwelling Foley catheter indicates urine output and response to fluid therapy.
  • An arterial line provides access for repeated blood draws, particularly in patients who are intubated or require admission to the ICU.
  • When meningitis or subarachnoid hemorrhage is suspected, lumbar puncture (LP) is indicated. If meningitis is suspected clinically, do not withhold antibiotics while waiting for the LP to be completed.
  TREATMENT Section 6 of 10   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

Prehospital Care: Standard care for dehydration and altered mental status is appropriate, including airway management, IV access, crystalloid, and any medications routinely given to coma patients.

  • Airway management is the top priority. In comatose patients in whom airway protection is of concern, endotracheal intubation may be indicated. Cervical spine immobilization is necessary if head or neck injury is a possibility.

  • IV access, large bore if possible, is useful, provided that attempts to obtain it do not significantly delay transfer to the nearest ED.
  • Bolus of 500 mL isotonic saline is appropriate for nearly all adults who are clinically dehydrated. A 250 mL bolus may be more appropriate in patients with a history of CHF and/or renal insufficiency.
  • Basic medications given to coma patients in the field may include thiamine 100 mg IV, dextrose (50 mL of D50), and naloxone (0.4-2 mg IV). This combination is of benefit to many comatose patients with few adverse effects.
  • When possible, fingerstick glucose measurement is obtained prior to dextrose administration. In any case in which fingerstick glucose measurement is unavailable or likely to be delayed, empiric D50 must be administered to comatose patients without delay. Undiagnosed and untreated hypoglycemia, which may present with signs and symptoms very similar to those of HHNC, is readily reversible but can be rapidly lethal if not treated promptly.

  • Whenever possible, contact the receiving facility while en route to ensure preparation for a comatose, dehydrated, and/or hyperglycemic patient.

  • Notify facility of possible brain attack when appropriate.
  • Use antibiotics as indicated based on clinical situation and likelihood of infection.

Emergency Department Care:

  • Manage airway as needed, establish IV access, initiate vigorous fluid resuscitation, and obtain appropriate laboratory and radiographic studies.
  • Fluid deficits in HHNC are large; the fluid deficit of an adult may be 10 L or more.
    • Administer 1-2 L of isotonic saline in the first 2 hours. A higher initial volume may be necessary in patients with severe volume depletion. Slower initial rates may be appropriate in patients with significant cardiac or renal disease or in those who are not urinating.
    • After the initial bolus, some clinicians recommend changing to half-normal saline, while others continue with isotonic saline.
    • Either fluid likely will replenish intravascular volume and correct hyperosmolarity; a good standard is to switch to half-normal saline once blood pressure and urine output are adequate.
    • Once serum glucose drops to 250 mg/dL, the patient must receive dextrose in the IV fluid.
  • Initiate insulin therapy in the ED.
    • Although many patients with HHNC respond to fluids alone, IV insulin in dosages similar to those used in DKA can facilitate correction of hyperglycemia.
    • Insulin utilized without concomitant vigorous fluid replacement increases risk of shock.
  • Frequent reevaluation of clinical and laboratory parameters is necessary.

Consultations:

  • Generally, no consultation is required to manage HHNC in the ED. After ED management, refer patient to a primary care physician, internist, or intensivist for further care.
  • In occasional cases, endocrinology, neurology, or infectious disease consultation may be useful.
  • Psychiatry consultation may be useful during the hospitalization.

  MEDICATION Section 7 of 10   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

Fluids, insulin, and electrolytes (especially potassium) are the cornerstones of management. Antipyretics, antiemetics, and antibiotics are added when appropriate to control fever and nausea/vomiting.

Drug Category: Insulin -- Although many patients with HHNC respond to fluids alone, IV insulin in dosages similar to those used in DKA can facilitate correction of hyperglycemia. Insulin utilized without concomitant vigorous fluid replacement increases risk of shock.
Drug Name
Insulin (Humulin, Humalog, Novolin) -- Used to reduce blood glucose levels and decrease ketogenesis. Some authors favor lower bolus and infusion dosages, with rationale that fluids are cornerstone of therapy and that disorder is more one of insulin resistance than of insulin deficiency. Furthermore, lowering serum glucose and serum osmolarity overly rapidly can result in complications.
Adult Dose0.1 U/kg IV once, followed by 0.1 U/kg/h
Pediatric Dose0.1 U/kg IV once (not to exceed 10 U), followed by 0.1 U/kg/h
Some authors recommend omitting loading dose; alternatively, IV doses of regular insulin can be given q1h, especially in patients who are not critically ill
ContraindicationsDocumented hypersensitivity; hypoglycemia
Interactions Medications that may decrease hypoglycemic effects of insulin include acetazolamide, AIDS antivirals, asparaginase, phenytoin, nicotine, isoniazid, diltiazem, diuretics, corticosteroids, thiazide diuretics, thyroid, estrogens, ethacrynic acid, calcitonin, oral contraceptives, diazoxide, dobutamine, phenothiazines, cyclophosphamide, dextrothyroxine, lithium carbonate, epinephrine, morphine sulfate, and niacin
Medications that may increase hypoglycemic effects of insulin include calcium, ACE inhibitors, alcohol, tetracyclines, beta-blockers, lithium carbonate, anabolic steroids, pyridoxine, salicylates, MAOIs, mebendazole, sulfonamides, phenylbutazone, chloroquine, clofibrate, fenfluramine, guanethidine, octreotide, pentamidine, and sulfinpyrazone
Pregnancy B - Usually safe but benefits must outweigh the risks.
PrecautionsHyperthyroidism may increase renal clearance of insulin, increasing need for insulin, while hypothyroidism may delay insulin turnover, decreasing need for insulin; monitor glucose carefully; dose adjustments may be necessary in patients with renal or hepatic dysfunction
Drug Category: Electrolytes -- These agents are used to replenish electrolytes depleted because of the presence of high blood glucose.
Drug Name
Potassium chloride (Klor-Con, K-Dur, Micro-K) -- Initial serum potassium in even reference range suggests intracellular potassium depletion. In virtually all cases of HHNC, supplemental potassium is necessary, as serum level drops secondary to insulin therapy and correction of metabolic acidosis.
Do not start until initial serum level is ascertained. Administer IV potassium cautiously, with attention to proper dosing and concentration. If patient can tolerate oral medications or has gastric tube in place, KCl can be repleted orally up to 60 mEq per dose, with dosing based upon frequently obtained lab values.
Adult Dose10-20 mEq IV over 1 h and prn based on frequently obtained lab values; adjust dosage to obtain serum levels of 4.5 mEq/L
In severe hypokalemia, consider infusions of up to 40 mEq over 1 h
Pediatric Dose0.5-0.75 mEq/kg slow IV infusion over 1-2 h initial dose; not to exceed 3 mEq/kg/d; adjust dosage to reach final serum levels of 4.5 mEq/dL
ContraindicationsHyperkalemia; renal failure; conditions in which potassium is retained; oliguria or azotemia; crush syndrome; severe hemolytic reactions; anuria; adrenocortical insufficiency
InteractionsACE inhibitors may result in elevated serum potassium concentrations; potassium-sparing diuretics and potassium-containing salt substitutes can produce severe hyperkalemia; digoxin in patients with hypokalemia may result in digoxin toxicity (caution if discontinuing potassium administration in patients maintained on digoxin)
Pregnancy A - Safe in pregnancy
PrecautionsDo not infuse rapidly; high plasma concentrations may cause death due to cardiac depression, arrhythmias, or arrest; plasma levels do not necessarily reflect tissue levels
Always administer IV potassium therapy with an infusion pump system designed to administer precise quantities per minute
Dosages and dilutions must be double checked to ensure they are correct; institute nursing protocols at each institution to ensure no dosing errors occur
Monitor potassium replacement therapy whenever possible by continuous or serial ECG; when concentration >40 mEq/L is infused, local pain and phlebitis may follow; vein sclerosis may occur in peripheral IV sites
Drug Category: Alkalinizing agent -- No evidence is found that sodium bicarbonate provides any benefit to patients with HHNC. It may be considered if a patient has significant acidosis (pH <7.0), particularly if inotropic agents are required to maintain blood pressure.
Drug Name
Sodium bicarbonate (NaHCO3) -- Bicarbonate ion produced on dissociation neutralizes hydrogen ions and raises urinary and blood pH.
Adult Dose44-88 mEq (1-2 ampules) IV q1-2h prn; if administered for very severe acidosis, almost always administer as IV infusion, not as IV bolus or push IV
Pediatric Dose1 mEq/kg IV q1-2h prn, as an IV infusion
ContraindicationsAlkalosis; hypernatremia; hypocalcemia; severe pulmonary edema
InteractionsUrinary alkalinization induced by increased sodium bicarbonate concentrations may cause decreased levels of lithium, tetracyclines, chlorpropamide, methotrexate, and salicylates; increases levels of amphetamines, pseudoephedrine, flecainide, anorexiants, mecamylamine, ephedrine, quinidine, and quinine
Pregnancy C - Safety for use during pregnancy has not been established.
PrecautionsSodium bicarbonate should be used to treat only documented metabolic acidosis and hyperkalemia-induced cardiac arrest; can cause alkalosis, decreased plasma potassium, hypocalcemia, and hypernatremia; caution in electrolyte imbalances such as in patients with CHF, cirrhosis, edema, corticosteroid use, or renal failure; avoid extravasation since can cause tissue necrosis
  FOLLOW-UP Section 8 of 10   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

Further Inpatient Care:

Further Outpatient Care:

In/Out Patient Meds:

Deterrence/Prevention:

Complications:

Prognosis:

  MISCELLANEOUS Section 9 of 10   Click here to go to the previous section in this topic Click here to go to the top of this page Click here to go to the next section in this topic
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

Medical/Legal Pitfalls:

  • Failure to manage the airway with endotracheal intubation when necessary
  • Failure to provide adequate fluid resuscitation (leading to shock)
  • Cerebral edema (more common in children) secondary to overly rapid hydration (especially with hypotonic fluids) or failure to add glucose to fluids when the level falls to less than 250 mg/dL
  • Hypoglycemia due to excessive insulin use without the initiation of glucose-containing fluids
  • Failure to replete potassium in patients who have a total body potassium deficit but an initially normal serum potassium level (On the other hand, administration of IV potassium has been associated with significant morbidity and death, especially with iatrogenic errors.)
  • Failure to treat empirically and early with broad-spectrum antibiotics when sepsis appears to be a possible precipitant
  BIBLIOGRAPHY Section 10 of 10   Click here to go to the previous section in this topic Click here to go to the top of this page
Author Information Introduction Clinical Differentials Workup Treatment Medication Follow-up Miscellaneous Bibliography

  • Chiasson JL, Aris-Jilwan N, Belanger R, et al: Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state. CMAJ 2003 Apr 1; 168(7): 859-66[Medline].
  • Cruz-Caudillo JC, Sabatini S: Diabetic hyperosmolar syndrome [editorial]. Nephron 1995; 69(3): 201-10[Medline].
  • Foster DW, McGarry JD: Diabetes mellitus: acute complications, ketoacidosis, hyperosmolar coma, lactic acidosis. In: DeGroot LJ, Besser M, Burger HG, eds. Endocrinology. 3rd ed. Philadelphia, Pa: WB Saunders Co; 1995:1506-21.
  • Gaglia JL, Wyckoff J, Abrahamson MJ: Acute hyperglycemic crisis in the elderly. Med Clin North Am 2004 Jul; 88(4): 1063-84, xii[Medline].
  • Genuth SM: Diabetic ketoacidosis and hyperglycemic hyperosmolar coma. Curr Ther Endocrinol Metab 1997; 6: 438-47[Medline].
  • Gonzalez-Campoy JM, Robertson RP: Diabetic ketoacidosis and hyperosmolar nonketotic state: gaining control over extreme hyperglycemic complications. Postgrad Med 1996 Jun; 99(6): 143-52[Medline].
  • Gottschalk ME, Ros SP, Zeller WP: The emergency management of hyperglycemic-hyperosmolar nonketotic coma in the pediatric patient. Pediatr Emerg Care 1996 Feb; 12(1): 48-51[Medline].
  • Gupta S, Prabhu MR, Gupta MS, Niblett D: Severe non-ketotic hyperosmolar coma--intensive care management. Eur J Anaesthesiol 1998 Sep; 15(5): 603-6[Medline].
  • Kitabchi AE, Murphy MB: Diabetic ketoacidosis and hyperosmolar hyperglycemic nonketotic coma. Med Clin North Am 1988 Nov; 72(6): 1545-63[Medline].
  • Lorber D: Nonketotic hypertonicity in diabetes mellitus. Med Clin North Am 1995 Jan; 79(1): 39-52[Medline].
  • MacIsaac RJ, Lee LY, McNeil KJ, et al: Influence of age on the presentation and outcome of acidotic and hyperosmolar diabetic emergencies. Intern Med J 2002 Aug; 32(8): 379-85[Medline].
  • Manford M, Fuller GN, Wade JP: "Silent diabetes": non-ketotic hyperglycaemia presenting as aphasic status epilepticus. J Neurol Neurosurg Psychiatry 1995 Jul; 59(1): 99-100[Medline].
  • Matz R: Management of the hyperosmolar hyperglycemic syndrome. Am Fam Physician 1999 Oct 1; 60(5): 1468-76[Medline].
  • Pinies JA, Cairo G, Gaztambide S, Vazquez JA: Course and prognosis of 132 patients with diabetic non ketotic hyperosmolar state. Diabete Metab 1994 Jan-Feb; 20(1): 43-8[Medline].
  • Rosa EC, Lopes AC, Liberatori Filho AW, Schor N: Rhabdomyolysis due to hyperosmolarity leading to acute renal failure. Ren Fail 1997 Mar; 19(2): 295-301[Medline].
  • Singh I, Marshall MC Jr: Diabetes mellitus in the elderly. Endocrinol Metab Clin North Am 1995 Jun; 24(2): 255-72[Medline].
  • Trence DL, Hirsch IB: Hyperglycemic crises in diabetes mellitus type 2. Endocrinol Metab Clin North Am 2001 Dec; 30(4): 817-31[Medline].
  • Umpierrez GE, Kelly JP, Navarrete JE, et al: Hyperglycemic crises in urban blacks. Arch Intern Med 1997 Mar 24; 157(6): 669-75[Medline].
  • Umpierrez GE, Khajavi M, Kitabchi AE: Review: diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic syndrome. Am J Med Sci 1996 May; 311(5): 225-33[Medline].
  • Wachtel TJ, Tetu-Mouradjian LM, Goldman DL, et al: Hyperosmolarity and acidosis in diabetes mellitus: a three-year experience in Rhode Island. J Gen Intern Med 1991 Nov-Dec; 6(6): 495-502[Medline].

Hyperosmolar Hyperglycemic Nonketotic Coma excerpt